http://www.rexahn.com
Rexahn Pharmaceuticals, Inc. Company Intro
Industry
Healthcare
Rexahn Pharmaceuticals, Inc. Headquaters
15245 Shady Grove Road
Rockville,20850
United States
Rexahn Pharmaceuticals, Inc. Share price
17 May 2023 13:48 GMT
$0
0.0 (0 %)
Rexahn Pharmaceuticals, Inc. Market cap
$
WMC RANKING
2024
Rexahn Pharmaceuticals, Inc. # 288
BiotechnologyLatest Rexahn Pharmaceuticals, Inc. News
07 Feb 2024
Marktumfang für fortschrittliche und gezielte Arzneimittelverabreichung: Neue Trends, Analysen und Prognosen für ...
Global Fortschrittliche und gezielte Arzneimittelabgabe Marktbericht bietet einen detaillierten Überblick über Fortschrittliche und gezielte...
07 Feb 2024
Marktumfang für fortschrittliche und gezielte Arzneimittelverabreichung: Neue Trends, Analysen und Prognosen für ...
Global Fortschrittliche und gezielte Arzneimittelabgabe Marktbericht bietet einen detaillierten Überblick über Fortschrittliche und gezielte...
WMC Market Score
WMC Market to Revenue Score
Rexahn Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Rexahn Pharmaceuticals, Inc. | USD | $0 | $11,215 | $-8,635 | $ 0.00 | 288 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Rexahn Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Rexahn Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Rexahn Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Rexahn Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Rexahn Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Rexahn Pharmaceuticals, Inc. | 0.01 | 0.05 | 0 | 0 | 0 | 0 | 0.02 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
